Lisanne E. Nijman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lisanne E. Nijman has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Louis Vermeulen
Laboratory of Experimental Oncology and Radiobiology, Cancer Center Amsterdam, Amsterdam UMC and University of Amsterdam, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands
7 shared publications Maria C. Lecca
Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Oncode Institute, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands
6 shared publicationsDaniël M. Miedema
Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Oncode Institute, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands
5 shared publicationsSophie C. Lodestijn
Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Oncode Institute, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands
5 shared publications- Edward Morrissey
MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DS, UK
4 shared publications - Maarten F. Bijlsma
Laboratory of Experimental Oncology and Radiobiology, Amsterdam UMC and University of Amsterdam, Amsterdam, the Netherlands
4 shared publications
Latest Publications
- Open Access
- 5 December 2022
- Published by Elsevier in Clinical Colorectal Cancer
- Vol. 22 (1) , 67-75
Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer
- 5 December 2022
- Published by Elsevier in Clinical Colorectal Cancer
- Vol. 22 (1) , 67-75
Open AccessLong-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer
- Open Access
- 2 November 2022
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 14 (12) , e16194
Intestinal Apc‐inactivation induces HSP25 dependency
The majority of colorectal cancers (CRCs) present with early mutations in tumor suppressor gene APC. APC mutations result in oncogenic activation of the Wnt pathway, which is associated with hyperproliferation, cytoskeletal remodeling, and a global increase in mRNA translation. To compensate for the increased biosynthetic demand, cancer cells critically depend on protein chaperones to maintain proteostasis, although their function in CRC remains largely unexplored. In order to investigate the role of molecular chaperones in driving CRC initiation, we captured the transcriptomic profiles of murine wild type and Apc‐mutant organoids during active transformation. We discovered a strong transcriptional upregulation of Hspb1, which encodes small heat shock protein 25 (HSP25). We reveal an indispensable role for HSP25 in facilitating Apc‐driven transformation, using both in vitro organoid cultures and mouse models, and demonstrate that chemical inhibition of HSP25 using brivudine reduces the development of premalignant adenomas. These findings uncover a hitherto unknown vulnerability in intestinal transformation that could be exploited for the development of chemopreventive strategies in high‐risk individuals.
- 2 November 2022
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 14 (12) , e16194
Open AccessIntestinal Apc‐inactivation induces HSP25 dependency
The majority of colorectal cancers (CRCs) present with early mutations in tumor suppressor gene APC. APC mutations result in oncogenic activation of the Wnt pathway, which is associated with hyperproliferation, cytoskeletal remodeling, and a global increase in mRNA translation. To compensate for the increased biosynthetic demand, cancer cells critically depend on protein chaperones to maintain proteostasis, although their function in CRC remains largely unexplored. In order to investigate the role of molecular chaperones in driving CRC initiation, we captured the transcriptomic profiles of murine wild type and Apc‐mutant organoids during active transformation. We discovered a strong transcriptional upregulation of Hspb1, which encodes small heat shock protein 25 (HSP25). We reveal an indispensable role for HSP25 in facilitating Apc‐driven transformation, using both in vitro organoid cultures and mouse models, and demonstrate that chemical inhibition of HSP25 using brivudine reduces the development of premalignant adenomas. These findings uncover a hitherto unknown vulnerability in intestinal transformation that could be exploited for the development of chemopreventive strategies in high‐risk individuals.
- Open Access
- 1 November 2021
- Published by Elsevier in Cell Stem Cell
- Vol. 28 (11) , 2009-2019.e4
Continuous clonal labeling reveals uniform progenitor potential in the adult exocrine pancreas
- 1 November 2021
- Published by Elsevier in Cell Stem Cell
- Vol. 28 (11) , 2009-2019.e4
Open AccessContinuous clonal labeling reveals uniform progenitor potential in the adult exocrine pancreas
- Open Access
- 1 October 2021
- Published by Elsevier in Cell Reports
- Vol. 37 (3) , 109852
Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer
- 1 October 2021
- Published by Elsevier in Cell Reports
- Vol. 37 (3) , 109852
Open AccessMarker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer
- 1 November 2020
- Published by Elsevier in Laboratory Investigation
- Vol. 100 (11) , 1465-1474
A mouse model for peritoneal metastases of colorectal origin recapitulates patient heterogeneity
- 1 November 2020
- Published by Elsevier in Laboratory Investigation
- Vol. 100 (11) , 1465-1474
A mouse model for peritoneal metastases of colorectal origin recapitulates patient heterogeneity
- Open Access
- 1 January 2020
- Published by Elsevier in SSRN Electronic Journal
Continuous Clonal Labeling Reveals Uniform Progenitor Potential in the Adult Exocrine Pancreas
The tissue dynamics that govern maintenance and regeneration of the pancreas remain largely unknown. In particular, the presence and nature of a cellular hierarchy remains a topic of debate. Previous lineage tracing strategies in the pancreas relied on specific marker genes for clonal labeling, which leaves other populations untested and fails to account for potential widespread phenotypical plasticity. Here we employed a tracing system that depends on replication-induced clonal marks. We found that in homeostasis, steady acinar replacement events characterize tissue dynamics, to which all acinar cells have an equal ability to contribute. Similarly, regeneration following pancreatitis was best characterized by an acinar self-replication model, as no evidence for a cellular hierarchy was detected. In particular, rapid regeneration in the pancreas was found to be driven by an accelerated rate of acinar fission events. Together these results provide a comprehensive and quantitative model of cell dynamics in the exocrine pancreas.
- 1 January 2020
- Published by Elsevier in SSRN Electronic Journal
Open AccessContinuous Clonal Labeling Reveals Uniform Progenitor Potential in the Adult Exocrine Pancreas
The tissue dynamics that govern maintenance and regeneration of the pancreas remain largely unknown. In particular, the presence and nature of a cellular hierarchy remains a topic of debate. Previous lineage tracing strategies in the pancreas relied on specific marker genes for clonal labeling, which leaves other populations untested and fails to account for potential widespread phenotypical plasticity. Here we employed a tracing system that depends on replication-induced clonal marks. We found that in homeostasis, steady acinar replacement events characterize tissue dynamics, to which all acinar cells have an equal ability to contribute. Similarly, regeneration following pancreatitis was best characterized by an acinar self-replication model, as no evidence for a cellular hierarchy was detected. In particular, rapid regeneration in the pancreas was found to be driven by an accelerated rate of acinar fission events. Together these results provide a comprehensive and quantitative model of cell dynamics in the exocrine pancreas.
- Open Access
- 8 March 2019
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (13) , 6140-6145
Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts
Significance: Colorectal cancer (CRC) is a heterogeneous disease, with significant variation in genotype and phenotype within each individual tumor. This intratumor heterogeneity emerges during tumor development due to clonal evolution and in part can explain therapy resistance in CRC. However, a detailed understanding of the spatiotemporal development of tumors underlying cancer evolution and intratumor heterogeneity remains absent. Here, we use lineage-tracing experiments of human CRC cells transplanted into immunocompromised mice, in combination with computational modeling, to study the growth mode of CRC. We found that the clonal position is crucial for clonal outgrowth. This demonstrates that, in addition to the genetic composition, the environment and the geometry of tumor growth play a significant role in shaping tumor evolution.
- 8 March 2019
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (13) , 6140-6145
Open AccessSpatiotemporal regulation of clonogenicity in colorectal cancer xenografts
Significance: Colorectal cancer (CRC) is a heterogeneous disease, with significant variation in genotype and phenotype within each individual tumor. This intratumor heterogeneity emerges during tumor development due to clonal evolution and in part can explain therapy resistance in CRC. However, a detailed understanding of the spatiotemporal development of tumors underlying cancer evolution and intratumor heterogeneity remains absent. Here, we use lineage-tracing experiments of human CRC cells transplanted into immunocompromised mice, in combination with computational modeling, to study the growth mode of CRC. We found that the clonal position is crucial for clonal outgrowth. This demonstrates that, in addition to the genetic composition, the environment and the geometry of tumor growth play a significant role in shaping tumor evolution.
- 3 September 2018
- Published by Springer Nature in Nature Cell Biology
- Vol. 20 (10) , 1193-1202
Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancer
Solid malignancies have been speculated to depend on cancer stem cells (CSCs) for expansion and relapse after therapy. Here we report on quantitative analyses of lineage tracing data from primary colon cancer xenograft tissue to assess CSC functionality in a human solid malignancy. The temporally obtained clone size distribution data support a model in which stem cell function in established cancers is not intrinsically, but is entirely spatiotemporally orchestrated. Functional stem cells that drive tumour expansion predominantly reside at the tumour edge, close to cancer-associated fibroblasts. Hence, stem cell properties change in time depending on the cell location. Furthermore, although chemotherapy enriches for cells with a CSC phenotype, in this context functional stem cell properties are also fully defined by the microenvironment. To conclude, we identified osteopontin as a key cancer-associated fibroblast-produced factor that drives in situ clonogenicity in colon cancer.
- 3 September 2018
- Published by Springer Nature in Nature Cell Biology
- Vol. 20 (10) , 1193-1202
Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancer
Solid malignancies have been speculated to depend on cancer stem cells (CSCs) for expansion and relapse after therapy. Here we report on quantitative analyses of lineage tracing data from primary colon cancer xenograft tissue to assess CSC functionality in a human solid malignancy. The temporally obtained clone size distribution data support a model in which stem cell function in established cancers is not intrinsically, but is entirely spatiotemporally orchestrated. Functional stem cells that drive tumour expansion predominantly reside at the tumour edge, close to cancer-associated fibroblasts. Hence, stem cell properties change in time depending on the cell location. Furthermore, although chemotherapy enriches for cells with a CSC phenotype, in this context functional stem cell properties are also fully defined by the microenvironment. To conclude, we identified osteopontin as a key cancer-associated fibroblast-produced factor that drives in situ clonogenicity in colon cancer.